Abstract
The objective of this study was to report the tolerability and toxicity of a regimen consisting of intravenous (IV) docetaxel and intraperitoneal (IP) cisplatin and paclitaxel with granulocyte colony-stimulating factor support. We conducted a retrospective cohort study of patients with surgical stage II-IV epithelial ovarian, fallopian tube or primary peritoneal carcinoma treated with an outpatient IP chemotherapy regimen consisting of docetaxel 75 mg/m IV and cisplatin 75 mg/m IP day 1 followed by paclitaxel 60 mg/m IP day 8 every 21 days. Grade 3 and 4 toxicity, dose delays and reductions, port complications, and tolerability are reported. Outcomes, including response rate, progression-free survival (PFS), overall survival (OS) are also reported. A total of 60 patients received this IP regimen. Most common toxicities included neutropenia (47%), gastrointestinal (28%), and anemia (25%). Most patients (85%) experienced no IP port complications. Dose delay or reduction was required in 30% of patients. Two-thirds completed all prescribed cycles, with 80% of total planned cycles completed. Complete response was achieved for 88%, and 43% are currently without evidence of disease. Median PFS for all patients was 25.5 months (95% con...Continue Reading
References
Dec 26, 1996·The New England Journal of Medicine·D S AlbertsB DuBeshter
Feb 13, 2001·British Journal of Cancer·P A VaseyS B Kaye
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MarkmanJ Sickel
Oct 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J RustinT Meyer
Nov 18, 2004·Journal of the National Cancer Institute·Paul A VaseyUNKNOWN Scottish Gynaecological Cancer Trials Group
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Dec 22, 2005·Gynecologic Oncology·Joan L WalkerDaniel Clarke-Pearson
Jan 6, 2006·The New England Journal of Medicine·Deborah K ArmstrongUNKNOWN Gynecologic Oncology Group
Apr 11, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E L Trimble, M C Christian
Dec 27, 2008·Gynecologic Oncology·Jenny M WhitworthJ Michael Straughn
Feb 10, 2009·Gynecologic Oncology·Emily BerryJulian Schink
Sep 22, 2009·Lancet·Noriyuki KatsumataUNKNOWN Japanese Gynecologic Oncology Group
Oct 25, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·C W Helm
Feb 15, 2012·Journal of Experimental & Clinical Cancer Research : CR·Ayako KimTakayuki Enomoto
Aug 21, 2013·The Lancet Oncology·Noriyuki KatsumataUNKNOWN Japanese Gynecologic Oncology Group
Jan 25, 2014·Chemotherapy·Chiara BattelliPanagiotis A Konstantinopoulos
Mar 5, 2016·The New England Journal of Medicine·John K ChanBradley J Monk
May 10, 2016·Obstetrics and Gynecology·Jason D WrightDawn L Hershman
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal